Recent Material Events - Barrier Therapeutics, Inc (BTRX)

Filing Date	Description
2008-08-07	In connection with the Merger (as defined below) and the Offer (as defined below), on August 4, 2008, Barrier Therapeutics, Inc. (the “Company”) repaid all amounts outstanding under that certain Credit and Security Agreement (the “Cred ...
2008-08-05	As previously disclosed, on June 23, 2008, Barrier Therapeutics, Inc. (the “Company”), Stiefel Laboratories, Inc. (“Stiefel”) and Bengal Acquisition Inc., a wholly owned subsidiary of Stiefel (“Bengal”), entered into an ...
2008-06-24	Stiefel agreed that Merger Sub would commence the Offer as promptly as reasonably practicable after the date of the Merger Agreement and in any event within 10 business days after the date of the Merger Agreement, and the Offer will remain open for n ...
2008-05-01	As previously disclosed, Barrier Therapeutics, Inc. (the “Company”) and Anne VanLent, the Company’s Executive Vice President, Chief Financial Officer and Treasurer, agreed to a mutual separation, whereby Ms. VanLent stepped down as Chi ...
2008-04-09	A copy of the press release is filed herewith as Exhibit 99.1 and is incorporated herein by reference. ...
2008-04-02	As previously disclosed, Barrier Therapeutics, Inc. (the “Company”) and Geert Cauwenbergh, Ph.D., the Company’s Chief Executive Officer, agreed to a mutual separation, whereby Dr. Cauwenbergh stepped down as Chief Executive Officer of ...
2008-03-25	A copy of the press release is filed herewith as Exhibit 99.1 and is incorporated herein by reference. ...
2008-03-17	As previously announced, effective April 1, 2008, Alfred Altomari, Barrier Therapeutics, Inc.’s (the “Company”) current Chief Operating Officer, will assume the role of Chief Executive Officer of the Company. In connection with his new ...
2008-01-28	On January 25, 2008, Barrier Therapeutics, Inc. (the “Company”) and Geert Cauwenbergh, Ph.D., the Company’s Chief Executive Officer, agreed to a mutual separation, whereby Dr. Cauwenbergh shall continue as the Chief Executive Officer o ...
2008-01-10	On January 8, 2008, Barrier Therapeutics, Inc. (the “Company”) entered into a Third Party Manufacturing Agreement (the “Agreement”) with Sanico NV (“Sanico”) under which Sanico will manufacture and supply the Company ...